Lantheus Expands Reach with Evergreen Theragnostics Acquisition, Enhancing Radiopharmaceutical Leadership Lantheus continues to strengthen its position in the radiopharmaceutical sector by acquiring Evergreen Theragnostics for $250 million, unlocking new growth avenues.

Lantheus Expands Reach with Evergreen Theragnostics Acquisition, Enhancing Radiopharmaceutical Leadership #USA #Bedford #Lantheus #Evergreen_Theragnostics #OCTEVY